From petri dish to patient:biotech’s formidable obstacle course
Bulls N’ Bears follows a biotech breakthrough from the laboratory to the patient and examines how Australian companies are negotiating the hurdles along the way.
We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.